Home/Filings/4/0001127602-23-022279
4//SEC Filing

Mitrano Richard J. 4

Accession 0001127602-23-022279

CIK 0001703647other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 4:02 PM ET

Size

7.7 KB

Accession

0001127602-23-022279

Insider Transaction Report

Form 4
Period: 2023-08-08
Mitrano Richard J.
VP Finance & Operations
Transactions
  • Sale

    Common Stock

    2023-08-08$0.67/sh241$16150,576 total
  • Sale

    Common Stock

    2023-08-09$0.66/sh238$15750,338 total
Holdings
  • Common Stock

    (indirect: By Trust)
    4,032
Footnotes (3)
  • [F1]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.661 to $0.675. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.660 to $0.662. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Issuer

Frequency Therapeutics, Inc.

CIK 0001703647

Entity typeother

Related Parties

1
  • filerCIK 0001785287

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:02 PM ET
Size
7.7 KB